Keywords: amgen, amg, aids, tumor, growth, reduction, biotechnology

Amgen's AMG 386 aids tumor growth reduction

Article | 21 April 2008

Print This

US biotechnology major Amgen has reported data from preclinical studies suggesting a significantly greater reduction in tumor growth when its ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in